HopeStage
Back to all studies
CompletedNCT06602492

Lower-nicotine e-cigarettes and exposure to nicotine

About this titleRead the official source — NCT06602492
Medication studyAges 21+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 21 years.

What did participation involve?

The protocol includes: Completing questionnaires.

Listed locations
RochesterSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: July 15, 2021
Recruitment status
Completed
Enrollment listed in the registry
72
Sponsor
Rochester Institute of Technology
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
Over 21 Years
Official registry ID
NCT06602492
Official title
Show the full official title

Compensatory Behavior of E-cig Users in Response to Reduced Nicotine E-liquids

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Rochester

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Rochester Institute of Technology, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Lower nicotine e-liquid and Higher nicotine eliquid.

Who was this study for?

Listed age limits: from 21 years.

Want to explore more studies?

Explore studies